High-risk antibiotic use common in nursing homes after hospitalization

Prescribing of drugs associated with C. diff infection and antibiotic-resistant pathogens.

1:58 PM

Author | Kelly Malcom

prescription pad

Patients who are discharged to nursing homes following hospitalization are routinely prescribed antibiotics, some of which leave them at high-risk for subsequent C. diff infections, according to a new study published in JAMA Network Open.

The study, led by Kyle J. Gontjes, M.P.H., of the University of Michigan Health Division of Geriatric & Palliative Medicine, Payel Patel, M.D., of the Division of Infectious Disease and others, analyzed patient data for antibiotic prescriptions during a hospital stay and at post-acute nursing home stays. Nearly two thirds of included patients received antibiotics during their care, with the majority initiated during hospitalization. Sixty-four percent of the antibiotics prescribed were considered high-risk as defined by the World Health Organization's AWARE categorization system, a set of guidelines designed to slow the development of antibiotic resistance.

Exposure to antibiotics was associated with rehospitalization and infection with C. diff, a bacterium that afflicts 200,000 people per year in health care settings, causing diarrhea, gut pain and other intestinal issues. Patients who received antibiotics also tended to have rooms contaminated with multidrug resistant organisms or vancomycin-resistant enterococci (germs that can no longer be killed with vancomycin, a drug typically used to treat C. diff) when compared to patients who did not receive antibiotics.

The study findings unveil an opportunity to better coordinate hospital antimicrobial stewardship programs with nursing home practices to reduce rates of C. diff infection, colonization by resistant pathogens and high-risk antibiotic prescribing.

Paper cited: "Association of Exposure to High-risk Antibiotics in Acute Care Hospitals With Multidrug-Resistant Organism Burden in Nursing Homes," JAMA Network Open. DOI: 10.1001/jamanetworkopen.2021.44959


More Articles About: Lab Notes Basic Science and Laboratory Research Community Health Nursing Homes All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories woman holding face looking stressed on white couch in white shirt dark blue pants
Health Lab
Health costs top older adults’ list of concerns for people their age, poll finds
People over 50 of all backgrounds say they’re most concerned about various kinds of health costs affecting people their age, including insurance, prescriptions, medical care, dental care and home or longterm care.
woman holding blackboard sign and poster next to her in purple
Health Lab
A mother’s tragedy leads to a new resource for grieving parents
Created by a patient and grieving parent, a peer and medically reviewed guidebook on pregnancy and infant loss offers others going through the same experience more resources during the difficult time.
kidneys blue yellow
Health Lab
Why personalized medicine is important in rare kidney disease
Building a comprehensive human kidney cell and tissue catalog could help develop more treatments for kidney disease.
Scientific illustration of gliobastoma cells in the brain
Health Lab
Path forward for glioblastoma treatment
Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
Xray of a stem cell in a mouse brain.
Health Lab
Stem cells improve memory, reduce inflammation in Alzheimer’s mouse brains
Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.
Illustration of a microscope
Health Lab
Helpful enzymes vanish in many patients with antiphospholipid syndrome
Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.